+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 4764593
The global clinical laboratory service market size is expected to reach USD 286.77 billion by 2030, registering a CAGR of 3.5% from 2024 to 2030. The growth of the industry can be attributed to the increasing prevalence of the geriatric population, which, in turn, is propelling the demand for early disease diagnosis. The growing prevalence of target diseases, such as diabetes and Cardiovascular Diseases (CVDs), is a high impact-rendering driver for industry growth over the forecast period. Cardiovascular disease is the leading cause of death globally. The presence of unmet medical needs pertaining to disease management and the subsequent increase in patient awareness in more regions are expected to boost the demand for clinical laboratory testing.

Improvements in laboratory testing technology throughbreakthrough and incremental advances are high-impact-rendering drivers for industry growth. Market firms are engaged in introducing new services to serve the unmet demand of patients. For instance, in May 2022, Hamilton County entered into a partnership with Ethos Laboratories for the launch of no-cost COVID-19 testing sites. In July 2022, Mayo Clinic laboratories launched monkeypox tests to increase availability and accessibility to a wider target population. Moreover, in January 2022, Quest Diagnostics launched COVID-19 rapid antigen tests available through QuestDirect in collaboration with eMed to provide access to testing for COVID-19 at home. The pandemic affected millions of people globally. According to the CDC and WHO, the standard for diagnosis of COVID-19 is RT-PCR for samples from the respiratory tract.

The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure is driving the industry. Due to this pandemic, there is an increase in the approval of tests for the diagnosis of the novel coronavirus, with most of these tests approved under Emergency Use Authorization (EUA) by federal agencies. Furthermore, the industry operates through different sales channels - laboratories and hospitals. The presence of prominent players in various regions is expected to drive the industry. For instance, in February 2022,Labcorp entered into a comprehensive partnership with Ascension. Through this collaboration, Labcorp will handle Ascension’s hospital-based labs situated in ten states for buying assets for its outreach laboratory business.

Clinical Laboratory Service Market Report Highlights

  • In 2021, the clinical chemistry segment held a dominant share owing to the increasing need for pathology analysis
  • The hospital-based laboratories segment is projected to grow at the fastest CAGR over the forecast period owing to increasing hospital-integrated laboratories
  • The bioanalytical & lab chemistry services segment was the highest revenue-generating segment in 2023 due to the increasing drug discovery and developmen
  • The industry has seen unprecedented growth due to the introduction of innovative services to address the rising demands
  • Asia Pacific is expected to witness the fastest CAGR during the forecast period due to improved manufacturing facilities and an increasing prevalence of chronic disease


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Clinical Laboratory Services Market: Methodology And Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
1.7 Global Market: Cagr Calculation
1.8 Global Market: Cagr Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.11 List Of Abbreviations
Chapter 2 Clinical Laboratory Services Market: Executive Summary
2.1 Clinical Laboratory Services Market: Market Outlook
2.1.1 Market Summary
Chapter 3 Clinical Laboratory Services Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Technological Advancements In The Filed Of Clinical Testing
3.3.1.2 Growing Prevalence Of Target Diseases Coupled With Rising Demand For Early Disease Diagnostic Tests
3.3.1.3 Introduction Of Novel Solutions
3.3.1.4 Introduction Of Home Health Tests
3.3.1.5 Outbreak Of Coivd-19 Technologies
3.3.2 Market Restraint Analysis
3.3.2.1 Presence Of Stringent Regulatory Framework
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4. Clinical Laboratory Services Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Clinical Laboratory Services Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Genetic Testing
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Clinical Chemistry
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Medical Microbiology Testing
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Hematology Testing
4.4.5. Immunology Testing
4.4.6. Cytology Testing
4.4.7. Drug of Abuse Testing
4.4.8. Other Esoteric Tests
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis
5.1. Service Provider Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Clinical Laboratory Services Market by Service Provider Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospital-Based Laboratories
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Stand-Alone Laboratories
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Clinic-Based Laboratories
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Clinical Laboratory Services Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Clinical Laboratory Services Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Bioanalytical & Lab Chemistry Services
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Toxicology Testing Services
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Cell & Gene Therapy Related Services
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Preclinical & Clinical Trial Related Services
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Drug Discovery & Development Related Services
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Others
6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Clinical Laboratory Services Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive scenario
7.8.4.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.5. Peru
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework/ reimbursement structure
7.8.5.3. Competitive scenario
7.8.5.4. Peru market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. QIAGEN NV
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. QUEST DIAGNOSTICS INCORPORATED
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. OPKO HEALTH, INC
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. CHARLES RIVER LABORATORIES
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. ARUP LABORATORIES (ASSOCIATED REGIONAL AND UNIVERSITY PATHOLOGISTS, INC.)
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. SONIC HEALTHCARE
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. NEOGENOMICS LABORATORIES, INC.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. FRESENIUS MEDICAL CARE AG & CO. KGAA
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. SIEMENS HEALTHCARE LIMITED
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. SYNLAB International GmbH
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Mayo Clinic Laboratories
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.3.16. Unilabs
8.3.16.1. Company overview
8.3.16.2. Financial performance
8.3.16.3. Product benchmarking
8.3.16.4. Strategic initiatives
8.3.17. Eurofins Scientific SE
8.3.17.1. Company overview
8.3.17.2. Financial performance
8.3.17.3. Product benchmarking
8.3.17.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America clinical laboratory services market, by region, 2018 - 2030 (USD Million)
Table 3 North America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 4 North America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 5 North America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 8 U.S. clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 9 Canada clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 11 Canada clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 12 Europe clinical laboratory services market, by region, 2018 - 2030 (USD Million)
Table 13 Europe clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 14 Europe clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 15 Europe clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 16 Germany clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 18 Germany clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 19 UK clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 20 UK clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 21 UK clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 22 France clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 23 France clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 24 France clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 25 Italy clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 27 Italy clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 28 Spain clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 30 Spain clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 32 Denmark clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 33 Denmark clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 35 Sweden clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 36 Sweden clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 37 Norway clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 38 Norway clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 39 Norway clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific clinical laboratory services market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 43 Asia Pacific clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 44 China clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 45 China clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 46 China clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 47 Japan clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 49 Japan clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 50 India clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 51 India clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 52 India clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 53 South Korea clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 54 South Korea clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 55 South Korea clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 56 Australia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 57 Australia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 58 Australia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 59 Thailand clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 60 Thailand clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 61 Thailand clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 63 Latin America clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 64 Latin America clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 65 Brazil clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 66 Brazil clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 67 Brazil clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 68 Mexico clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 69 Mexico clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 70 Mexico clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 71 Argentina clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 72 Argentina clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 73 Argentina clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 74 Colombia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 75 Colombia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 76 Colombia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 77 Peru clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 78 Peru clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 79 Peru clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 80 MEA clinical laboratory services market, by region, 2018 - 2030 (USD Million)
Table 81 MEA clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 82 MEA clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 83 MEA clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 84 South Africa clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 85 South Africa clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 86 South Africa clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 90 UAE clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 91 UAE clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 92 UAE clinical laboratory services market, by application, 2018 - 2030 (USD Million)
Table 93 Kuwait clinical laboratory services market, by test type, 2018 - 2030 (USD Million)
Table 94 Kuwait clinical laboratory services market, by service provider, 2018 - 2030 (USD Million)
Table 95 Kuwait clinical laboratory services market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical laboratory services market: market outlook
Fig. 14 Clinical laboratory services competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical laboratory services market driver impact
Fig. 20 Clinical laboratory services market restraint impact
Fig. 21 Clinical laboratory services market strategic initiatives analysis
Fig. 22 Clinical laboratory services market: Test Type movement analysis
Fig. 23 Clinical laboratory services market: Test Type outlook and key takeaways
Fig. 24 Genetic Testing market estimates and forecast, 2018 - 2030
Fig. 25 Clinical chemistry market estimates and forecast, 2018 - 2030
Fig. 26 Routine chemistry testing market estimates and forecast, 2018 - 2030
Fig. 27 Therapeutic drug monitoring testing market estimates and forecast, 2018 - 2030
Fig. 28 Endocrinology chemistry testing market estimates and forecast, 2018 - 2030
Fig. 29 Specialized chemistry testing market estimates and forecast, 2018 - 2030
Fig. 30 Other clinical chemistry testing market estimates and forecast, 2018 - 2030
Fig. 31 Medical microbiology testing market estimates and forecast, 2018 - 2030
Fig. 32 Infectious disease testing market estimates and forecast, 2018 - 2030
Fig. 33 Transplant diagnostic testing market estimates and forecast, 2018 - 2030
Fig. 34 Other microbiology testing market estimates and forecast, 2018 - 2030
Fig. 35 Hematology testing market estimates and forecast, 2018 - 2030
Fig. 36 Immunology testing market estimates and forecast, 2018 - 2030
Fig. 37 Cytology testing market estimates and forecast, 2018 - 2030
Fig. 38 Drug of abuse testing market estimates and forecast, 2018 - 2030
Fig. 39 Other esoteric tests market estimates and forecast, 2018 - 2030
Fig. 40 Clinical laboratory services market: Service Provider movement Analysis
Fig. 41 Clinical laboratory services market: Service Provider outlook and key takeaways
Fig. 42 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
Fig. 43 Stand-alone laboratories market estimates and forecasts,2018 - 2030
Fig. 44 Clinic-based laboratories market estimates and forecasts,2018 - 2030
Fig. 45 Clinical laboratory services market: application movement analysis
Fig. 46 Fig. .46 Clinical laboratory services market: application outlook and key takeaways
Fig. 47 Bioanalytical & lab chemistry services market estimates and forecasts, 2018 - 2030
Fig. 48 Toxicology testing services market estimates and forecasts,2018 - 2030
Fig. 49 Cell & gene therapy related services market estimates and forecasts, 2018 - 2030
Fig. 50 Preclinical & clinical trial related services market estimates and forecasts,2018 - 2030
Fig. 51 Drug discovery & development related services market estimates and forecasts, 2018 - 2030
Fig. 52 Other clinical laboratory services market estimates and forecasts,2018 - 2030
Fig. 53 Global clinical laboratory services market: Regional movement analysis
Fig. 54 Global clinical laboratory services market: Regional outlook and key takeaways
Fig. 55 Global clinical laboratory services market share and leading players
Fig. 56 North America market share and leading players
Fig. 57 Europe market share and leading players
Fig. 58 Asia Pacific market share and leading players
Fig. 59 Latin America market share and leading players
Fig. 60 Middle East & Africa market share and leading players
Fig. 61 North America: SWOT
Fig. 62 Europe SWOT
Fig. 63 Asia Pacific SWOT
Fig. 64 Latin America SWOT
Fig. 65 MEA SWOT
Fig. 66 North America
Fig. 67 North America market estimates and forecasts, 2018 - 2030
Fig. 68 U.S.
Fig. 69 U.S. market estimates and forecasts, 2018 - 2030
Fig. 70 Canada
Fig. 71 Canada market estimates and forecasts, 2018 - 2030
Fig. 72 Europe
Fig. 73 Europe market estimates and forecasts, 2018 - 2030
Fig. 74 UK
Fig. 75 UK market estimates and forecasts, 2018 - 2030
Fig. 76 Germany
Fig. 77 Germany market estimates and forecasts, 2018 - 2030
Fig. 78 France
Fig. 79 France market estimates and forecasts, 2018 - 2030
Fig. 80 Italy
Fig. 81 Italy market estimates and forecasts, 2018 - 2030
Fig. 82 Spain
Fig. 83 Spain market estimates and forecasts, 2018 - 2030
Fig. 84 Denmark
Fig. 85 Denmark market estimates and forecasts, 2018 - 2030
Fig. 86 Sweden
Fig. 87 Sweden market estimates and forecasts, 2018 - 2030
Fig. 88 Norway
Fig. 89 Norway market estimates and forecasts, 2018 - 2030
Fig. 90 Asia Pacific
Fig. 91 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 92 China
Fig. 93 China market estimates and forecasts, 2018 - 2030
Fig. 94 Japan
Fig. 95 Japan market estimates and forecasts, 2018 - 2030
Fig. 96 India
Fig. 97 India market estimates and forecasts, 2018 - 2030
Fig. 98 Thailand
Fig. 99 Thailand market estimates and forecasts, 2018 - 2030
Fig. 100 South Korea
Fig. 101 South Korea market estimates and forecasts, 2018 - 2030
Fig. 102 Australia
Fig. 103 Australia market estimates and forecasts, 2018 - 2030
Fig. 104 Latin America
Fig. 105 Latin America market estimates and forecasts, 2018 - 2030
Fig. 106 Brazil
Fig. 107 Brazil market estimates and forecasts, 2018 - 2030
Fig. 108 Mexico
Fig. 109 Mexico market estimates and forecasts, 2018 - 2030
Fig. 110 Colombia
Fig. 111 Colombia market estimates and forecasts, 2018 - 2030
Fig. 112 Peru
Fig. 113 Peru market estimates and forecasts, 2018 - 2030
Fig. 114 Argentina
Fig. 115 Argentina market estimates and forecasts, 2018 - 2030
Fig. 116 Middle East and Africa
Fig. 117 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 118 South Africa
Fig. 119 South Africa market estimates and forecasts, 2018 - 2030
Fig. 120. Saudi Arabia
Fig. 121 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 122UAE
Fig. 123 UAE market estimates and forecasts, 2018 - 2030
Fig. 124 Kuwait
Fig. 125 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 126 Market share of key market players - Clinical laboratory services market

Companies Mentioned

  • LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
  • QIAGEN NV
  • QUEST DIAGNOSTICS INCORPORATED
  • OPKO HEALTH, INC
  • CHARLES RIVER LABORATORIES
  • ARUP LABORATORIES (ASSOCIATED REGIONAL AND UNIVERSITY PATHOLOGISTS, INC.)
  • SONIC HEALTHCARE
  • NEOGENOMICS LABORATORIES, INC.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • SIEMENS HEALTHCARE LIMITED
  • SYNLAB International GmbH
  • Mayo Clinic Laboratories
  • Unilabs
  • Eurofins Scientific SE

Methodology

Loading
LOADING...

Table Information